Introduction: Hypertension control in clinical practice with a new standard in angiotensin II receptor blockade

American Journal of Hypertension

Volumn 15, Issue 10 II, 2002, Pages

  Cushman, William C ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LOSARTAN; OLMESARTAN; ANGIOTENSIN RECEPTOR;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; KIDNEY FUNCTION; MICROALBUMINURIA; PATHOGENESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STANDARD; DRUG ANTAGONISM; REVIEW;

ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; RECEPTORS, ANGIOTENSIN;

EID: 0036782015     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(02)03003-0     Document Type: Editorial

References (4)

1. Hansson L: Hypertension management in 2002: Where have we been? Where might we be going? Am J Hypertens 2002;15:101S-107S.
2. Smith DHG: Strategies to meet lower blood pressure goals with a new standard in angiotensin II receptor blockade. Am J Hypertens 2002;15:108S-114S.
3. Schiffrin EL: Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002;15:115S-122S.
4. Lewis EJ: The role of angiotensin II receptor blockers in preventing the progression of renal disease in patients with type 2 diabetes. Am J Hypertens 2002;15:123S-128S.